Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Bullboard Posts
Comment by aeeon Apr 22, 2013 6:14pm
98 Views
Post# 21285981

RE: RE: Ugh!

RE: RE: Ugh!

I was one of the yahoos that was hoping for an announcement in the first quarter. 

 

A share price of 0.50 seems quite possible to me, if deals for the two lead compounds are announced.  That may be starting to look like an iffy kind of "if", but there really is no way for us to tell at this point (well, at least I can't).   This is purely a speculation.  

 

The problem for the speculator here is calculating which is declining faster - the share price or the risk/reward ratio.   Even if the probablility of success drops with time, it probably does not drop as fast as the share price.  

 

This will continue to drift down, but, mathematically, it may not be a worse speculation now than at 10 cents or 12 cents.   As it is, you only need a 20% chance of reaching 50 cents to have an expected value of 10 cents.  The DD I've done make me think the odds are better than 20%, even if they seem somewhat lower than they did in January.

-a

 

 

 

Bullboard Posts